Retinal microglia in glaucoma

Journal of Glaucoma

Volumn 25, Issue 5, 2016, Pages 459-465

  Wang, Jia Wei ^a   Chen, Shi Da ^a   Zhang, Xiu Lan ^a   Jonas, Jost B ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

microglia targeted therapy; optic nerve crush; retina; retinal astrocytes; retinal ganglion cells; retinal microglia

Indexed keywords

DEXAMETHASONE; TRIAMCINOLONE;

ASTROCYTE; BLOOD BRAIN BARRIER; BLOOD RETINA BARRIER; CELL LOSS; EPENDYMA CELL; GLAUCOMA; GLIA CELL; HUMAN; IMMUNOCOMPETENT CELL; MEDLINE; MICROGLIA; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA GANGLION CELL; REVIEW; ANIMAL; APOPTOSIS; INTRAOCULAR PRESSURE; OPTIC NERVE DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; BLOOD-RETINAL BARRIER; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MICROGLIA; OPTIC NERVE DISEASES; RETINAL GANGLION CELLS;

EID: 84922246287     PISSN: 10570829     EISSN: 1536481X     Source Type: Journal    
DOI: 10.1097/IJG.0000000000000200     Document Type: Review

References (100)

1. Ellis-Behnke RG, Jonas RA, Jonas JB. The microglial system in the eye and brain in response to stimuli in vivo. J Glaucoma. 2013;22(suppl 5):S32-S35.
2. McCarthy CA, Widdop RE, Deliyanti D, et al. Brain and retinal microglia in health and disease: an unrecognized target of the renin-Angiotensin system. Clin Exp Pharmacol Physiol. 2013;40:571-579.
3. Sawada M. Neuroprotective and toxic changes in microglia in neurodegenerative disease. Parkinsonism Relat Disord. 2009; 15(suppl 1):S39-S41.
4. Aldskogius H. Microglia in neuroregeneration. Microsc Res Tech. 2001;54:40-46.
5. Joachim SC, Gramlich OW, Laspas P, et al. Retinal ganglion cell loss is accompanied by antibody depositions and increased levels of microglia after immunization with retinal antigens. PLoS One. 2012;7:e40616.
6. Ibrahim AS, El-Remessy AB, Matragoon S, et al. Retinal microglial activation and inflammation induced by amadoriglycated albumin in a rat model of diabetes. Diabetes. 2011;60:1122-1133.
7. Zhang C, Guo Y, Miller NR, et al. Optic nerve infarction and post-ischemic inflammation in the rodent model of anterior ischemic optic neuropathy (rAION). Brain Res. 2009;1264: 67-75.
8. Slater BJ, Vilson FL, Guo Y, et al. Optic nerve inflammation and demyelination in a rodent model of nonarteritic anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2013; 54:7952-7961.
9. Sawada M. Brain cytokine network and novel characteristics of microglia. Nihon Shinkei Seishin Yakurigaku Zasshi. 1999; 19:151-154.
10. Azevedo FA, Carvalho LR, Grinberg LT, et al. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J Comp Neurol. 2009;513:532-541.
11. Lawson LJ, Perry VH, Dri P, et al. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience. 1990;39:151-170.
12. Chan WY, Kohsaka S, Rezaie P. The origin and cell lineage of microglia: new concepts. Brain Res Rev. 2007;53:344-354.
13. Cuoghi B, Mola L. Macroglial cells of the teleost central nervous system: a survey of the main types. Cell Tissue Res. 2009;338:319-332.
14. Reichenbach A, Derouiche A, Kirchhoff F. Morphology and dynamics of perisynaptic glia. Brain Res Rev. 2010;63:11-25.
15. Soulet D, Rivest S. Bone-marrow-derived microglia: myth or reality. Curr Opin Pharmacol. 2008;8:508-518.
16. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19:71-82.
17. Mildner A, Schmidt H, NitscheM, et al. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci. 2007;10:1544-1553.
18. Chen M, Zhao J, Luo C, et al. Para-inflammation-mediated retinal recruitment of bone marrow-derived myeloid cells following whole-body irradiation is CCL2 dependent. Glia. 2012;60:833-842.
19. Alliot F, Godin I, Pessac B. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res Dev Brain Res. 1999;117:145-152.
20. Vilhardt F. Microglia: phagocyte and glia cell. Int J Biochem Cell Biol. 2005;37:17-21.
21. Pachter JS, de Vries HE, Fabry Z. The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol. 2003;62:593-604.
22. Lampron A, Elali A, Rivest S. Innate immunity in the CNS: redefining the relationship between the CNS and Its environment. Neuron. 2013;78:214-232.
23. Toku K, Tanaka J, Yano H, et al. Microglial cells prevent nitric oxide-induced neuronal apoptosis in vitro. J Neurosci Res. 1998;53:415-425.
24. Benveniste EN. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med (Berl). 1997;75:165-173.
25. Aloisi F. Immune function of microglia. Glia. 2001;36: 165-179.
26. Jonas RA, Yuan TF, Liang YX, et al. The spider effect: morphological and orienting classification of microglia in response to stimuli in vivo. PLoS One. 2012;7:e30763.
27. Yu TB, Cheng YS, Zhao P, et al. Immune therapy with cultured microglia grafting into the injured spinal cord promoting the recovery of rat's hind limb motor function. Chin J Traumatol. 2009;12:291-295.
28. Wirenfeldt M, Babcock AA, Vinters HV. Microglia-insights into immune system structure, function, and reactivity in the central nervous system. Histol Histopathol. 2011;26: 519-530.
29. Lynch MA. The multifaceted profile of activated microglia. Mol Neurobiol. 2009;40:139-156.
30. Batchelor PE, Porritt MJ, Martinello P, et al. Macrophages and microglia produce local trophic gradients that stimulate axonal sprouting toward but not beyond the wound edge. Mol Cell Neurosci. 2002;21:436-453.
31. Dick AD, Carter D, Robertson M, et al. Control of myeloid activity during retinal inflammation. J Leukoc Biol. 2003;74: 161-166.
32. Karlstetter M, Nothdurfter C, Aslanidis A, et al. Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis. J Neuroinflammation. 2014;11:3.
33. Nathan C, Muller WA. Putting the brakes on innate immunity: a regulatory role for CD200. Nat Immunol. 2001;2: 17-19.
34. Wolf Y, Yona S, Kim KW, et al. Microglia, seen from the CX3CR1 angle. Front Cell Neurosci. 2013;7:26.
35. Raibon E, Sauve Y, Carter DA, et al. Microglial changes accompanying the promotion of retinal ganglion cell axonal regeneration into peripheral nerve grafts. J Neurocytol. 2002; 31:57-71.
36. Jeon GS, Kang TC, Park SW, et al. Microglial responses in the avascular quail retina following transection of the optic nerve. Brain Res. 2004;1023:15-23.
37. Saraswathy S, Wu G, Rao NA. Retinal microglial activation and chemotaxis by docosahexaenoic acid hydroperoxide. Invest Ophthalmol Vis Sci. 2006;47:3656-3663.
38. Santos AM, Martin-Oliva D, Ferrer-Martin RM, et al. Microglial response to light-induced photoreceptor degeneration in the mouse retina. J Comp Neurol. 2010;518: 477-492.
39. Kaur C, Rathnasamy G, Ling EA. Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina. J Neuroimmune Pharmacol. 2013;8:66-78.
40. Pham VT, Wen L, McCluskey P, et al. Human retinal microglia express candidate receptors for HIV-1 infection. Br J Ophthalmol. 2005;89:753-757.
41. Ardeljan D, Chan CC. Aging is not a disease: distinguishing age-related macular degeneration from aging. Prog Retin Eye Res. 2013;37:68-89.
42. Moss DW, Bates TE. Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NOmediated decreases in mitochondrial and cellular function. Eur J Neurosci. 2001;13:529-538.
43. Ebert S, Walczak Y, Reme C, et al. Microglial activation and transcriptomic changes in the blue light-exposed mouse retina. Adv Exp Med Biol. 2012;723:619-632.
44. Sivakumar V, Foulds WS, Luu CD, et al. Retinal ganglion cell death is induced by microglia derived pro-inflammatory cytokines in the hypoxic neonatal retina. J Pathol. 2011;224: 245-260.
45. Block ML, Hong JS. Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochem Soc Trans. 2007;35:1127-1132.
46. Kohno T, Inomata H, Taniguchi Y. Identification of microglia cell of the rat retina by light and electron microscopy. Jpn J Ophthalmol. 1982;26:53-68.
47. Balaratnasingam C, Kang MH, Yu P, et al. Comparative quantitative study of astrocytes and capillary distribution in optic nerve laminar regions. Exp Eye Res. 2014;121:11-22.
48. Navascues J, Moujahid A, Almendros A, et al. Origin of microglia in the quail retina: central-To-peripheral and vitrealto-scleral migration of microglial precursors during development. J Comp Neurol. 1995;354:209-228.
49. Chen L, Yang P, Kijlstra A. Distribution, markers, and functions of retinal microglia. Ocul Immunol Inflamm. 2002;10:27-39.
50. Provis JM, Penfold PL, Edwards AJ, et al. Human retinal microglia: expression of immune markers and relationship to the glia limitans. Glia. 1995;14:243-256.
51. Neufeld AH. Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. Arch Ophthalmol. 1999;117:1050-1056.
52. McMenamin PG. Subretinal macrophages in the developing eye of eutherian mammals and marsupials. Anat Embryol (Berl). 1999;200:551-558.
53. Liu B, Hong JS. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther. 2003;304:1-7.
54. Sawada M, Sawada H, Nagatsu T. Effects of aging on neuroprotective and neurotoxic properties of microglia in neurodegenerative diseases. Neurodegener Dis. 2008;5: 254-256.
55. Smith JA, Das A, Ray SK, et al. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull. 2012;87:10-20.
56. Lull ME, Block ML. Microglial activation and chronic neurodegeneration. Neurotherapeutics. 2010;7:354-365.
57. Loane DJ, Kumar A, Stoica BA, et al. Progressive neurodegeneration after experimental brain trauma: association with chronic microglial activation. J Neuropathol Exp Neurol. 2014;73:14-29.
58. Cuenca N, Fernandez-Sanchez L, Campello L, et al. Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases. Prog Retin Eye Res. 2014;43C:17-75.
59. Maneu V, Noailles A, Megias J, et al. Retinal microglia are activated by systemic fungal infection. Invest Ophthalmol Vis Sci. 2014;55:3578-3585.
60. Chiu K, Yeung SC, So KF, et al. Modulation of morphological changes of microglia and neuroprotection by monocyte chemoattractant protein-1 in experimental glaucoma. Cell Mol Immunol. 2010;7:61-68.
61. Bosco A, Steele MR, Vetter ML. Early microglia activation in a mouse model of chronic glaucoma. J Comp Neurol. 2011; 519:599-620.
62. Gallego BI, Salazar JJ, de Hoz R, et al. IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma. J Neuroinflammation. 2012;9:92.
63. Bosco A, Crish SD, Steele MR, et al. Early reduction of microglia activation by irradiation in a model of chronic glaucoma. PLoS One. 2012;7:e43602.
64. Naskar R, Wissing M, Thanos S. Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma. Invest Ophthalmol Vis Sci. 2002;43:2962-2968.
65. Jonas JB, Nguyen XN, Gusek GC, et al. Parapapillary chorioretinal atrophy in normal and glaucoma eyes. I. Morphometric data. Invest Ophthalmol Vis Sci. 1989;30: 908-918.
66. Jonas JB, Naumann GO. Parapapillary chorioretinal atrophy in normal and glaucoma eyes. II. Correlations. Invest Ophthalmol Vis Sci. 1989;30:919-926.
67. Jonas JB, Xu L. Parapapillary chorioretinal atrophy in normal-pressure glaucoma. Am J Ophthalmol. 1993;115: 501-505.
68. Suh HS, Zhao ML, Derico L, et al. Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators. J Neuroinflammation. 2013;10:37.
69. Rappert A, Bechmann I, Pivneva T, et al. CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J Neurosci. 2004;24:8500-8509.
70. Dheen ST, Jun Y, Yan Z, et al. Retinoic acid inhibits expression of TNF-Alpha and iNOS in activated rat microglia. Glia. 2005;50:21-31.
71. Luo C, Yang X, Kain AD, et al. Glaucomatous tissue stress and the regulation of immune response through glial Toll-like receptor signaling. Invest Ophthalmol Vis Sci. 2010;51: 5697-5707.
72. Baby N, Patnala R, Ling EA, et al. Nanomedicine and its application in treatment of microglia-mediated neuroinflammation. Curr Med Chem. 2014;21:4215-4226.
73. Abraham J, Fox PD, Condello C, et al. Minocycline attenuates microglia activation and blocks the long-Term epileptogenic effects of early-life seizures. Neurobiol Dis. 2012;46:425-430.
74. Kohman RA, Bhattacharya TK, Kilby C, et al. Effects of minocycline on spatial learning, hippocampal neurogenesis and microglia in aged and adult mice. Behav Brain Res. 2013;242:17-24.
75. Liu X, Su H, Chu TH, et al. Minocycline inhibited the proapoptotic effect of microglia on neural progenitor cells and protected their neuronal differentiation in vitro. Neurosci Lett. 2013;542:30-36.
76. Hughes EH, Schlichtenbrede FC, Murphy CC, et al. Minocycline delays photoreceptor death in the rds mouse through a microglia-independent mechanism. Exp Eye Res. 2004;78: 1077-1084.
77. Zhang C, Lei B, Lam TT, et al. Neuroprotection of photoreceptors by minocycline in light-induced retinal degeneration. Invest Ophthalmol Vis Sci. 2004;45:2753-2759.
78. Hong J, Kim BK, Lim H, et al. Identification and characterization of triamcinolone acetonide, a microglial-Activation inhibitor. Immunopharmacol Immunotoxicol. 2012;34: 912-918.
79. Nomoto H, Lavinsky D, Paulus YM, et al. Effect of intravitreal triamcinolone acetonide on healing of retinal photocoagulation lesions. Retina. 2013;33:63-70.
80. Karalezli A, Borazan M, Kucukerdonmez C, et al. Effect of intracameral triamcinolone acetonide on postoperative intraocular pressure after cataract surgery. Eye (Lond). 2010;24:619-623.
81. Wang B, Dong N, Xu B, et al. Efficacy and safety of intracameral triamcinolone acetonide to control postoperative inflammation after phacotrabeculectomy. J Cataract Refract Surg. 2013;39:1691-1697.
82. Karalezli A, Borazan M, Akova YA. Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification. Acta Ophthalmol. 2008;86:183-187.
83. Cleary CA, Lanigan B, O'Keeffe M. Intracameral triamcinolone acetonide after pediatric cataract surgery. J Cataract Refract Surg. 2010;36:1676-1681.
84. Demir M, Oba E, Guven D, et al. Results of intravitreal triamcinolone acetonide in patients with macular edema secondary to branch retinal vein occlusion. Int J Clin Pharm. 2014;36:438-442.
85. Choi DK, Koppula S, Suk K. Inhibitors of microglial neurotoxicity: focus on natural products. Molecules. 2011;16:1021-1043.
86. Wang S, Wang H, Guo H, et al. Neuroprotection of Scutellarin is mediated by inhibition of microglial inflammatory activation. Neuroscience. 2011;185:150-160.
87. Wu Z, Zhu A, Takayama F, et al. Brazilian green propolis suppresses the hypoxia-induced neuroinflammatory responses by inhibiting NF-kappaB activation in microglia. Oxid Med Cell Longev. 2013;2013:906726.
88. Zeng KW, Fu H, Liu GX, et al. Icariin attenuates lipopolysaccharide-induced microglial activation and resultant death of neurons by inhibiting TAK1/IKK/NF-kappaB and JNK/p38 MAPK pathways. Int Immunopharmacol. 2010; 10:668-678.
89. Corbit RM, Ferreira JF, Ebbs SD, et al. Simplified extraction of ginsenosides from American ginseng (Panax quinquefolius L) for high-performance liquid chromatography-ultraviolet analysis. J Agric Food Chem. 2005;53:9867-9873.
90. Guo L, Xing Y, Pan R, et al. Curcumin protects microglia and primary rat cortical neurons against HIV-1 gp120-mediated inflammation and apoptosis. PLoS One. 2013;8: e70565.
91. Afzal M, Al-Hadidi D, Menon M, et al. Ginger: an ethnomedical, chemical and pharmacological review. Drug Metabol Drug Interact. 2001;18:159-190.
92. Yang F, Wu L, Guo X, et al. Improved retinal ganglion cell survival through retinal microglia suppression by a Chinese herb extract, triptolide, in the DBA/2 J mouse model of glaucoma. Ocul Immunol Inflamm. 2013;21:378-389.
93. Yue YK, Mo B, Zhao J, et al. Neuroprotective effect of curcumin against oxidative damage in BV-2 microglia and high intraocular pressure animal model. J Ocul Pharmacol Ther. 2014;PubMed ID:24963995.
94. Tanaka S, Ishii A, Ohtaki H, et al. Activation of microglia induces symptoms of Parkinson's disease in wild-Type, but not in IL-1 knockout mice. J Neuroinflammation. 2013;10:143.
95. Yuan L, Neufeld AH. Tumor necrosis factor-Alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia. 2000;3 2:42-50.
96. Roh M, Zhang Y, Murakami Y, et al. Etanercept, a widely used inhibitor of tumor necrosis factor-Alpha (TNF-Alpha), prevents retinal ganglion cell loss in a rat model of glaucoma. PLoS One. 2012;7:e40065.
97. Yeo YA, Martinez GJM, Croxford JL, et al. CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species. J Neuroinflammation. 2012;9:173.
98. Cameron JS, Alexopoulou L, Sloane JA, et al. Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci. 2007;27:13033-13041.
99. Lin S, Liang Y, Zhang J, et al. Microglial TIR-domaincontaining adapter-inducing interferon-beta (TRIF) deficiency promotes retinal ganglion cell survival and axon regeneration via nuclear factor-kappaB. J Neuroinflammation. 2012;9:39.
100. Thored P, Heldmann U, Gomes-Leal W, et al. Long-Term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. Glia. 2009;57:835-849.